| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |